Milestone Pharmaceuticals Inc. Common Shares

MISTNASDAQUSD
1.24 USD
0.01 (0.80%)AT CLOSE (11:59 AM EDT)
1.27
0.03 (2.02%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
1.27
0.03 (2.02%)
🔴Market: CLOSED

Shares of Milestone Pharmaceuticals Inc. Common Shares (MIST) are trading at $1.24. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (348.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, MIST is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 26, 2026.

Open?$1.25
High?$1.27
Low?$1.23
Prev. Close?$1.25
Volume?915.0K
Avg. Volume?1.4M
VWAP?$1.25
Rel. Volume?0.64x
Bid / Ask
Bid?$1.24 × 100
Ask?$1.25 × 200
Spread?$0.01
Midpoint?$1.25
Valuation & Ratios
Market Cap?154.4M
Shares Out?124.5M
Float?104.3M
Float %?87.2%
P/E Ratio?N/A
P/B Ratio?-7.88
EPS?-$0.55
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Employees
38
Market Cap
155.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2019-05-09
Address
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
24
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.91Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.16%High
Short Interest?10.6M
Days to Cover?8.7
Free Float104.3M
Avg Daily Volume1.2M
Settlement Date2026-06-15
Financial Health
Current Ratio?9.18Strong
Quick Ratio?9.09Strong
Cash Ratio?3.41Strong
Debt/Equity?-6.95Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
S&P
97
-7.88CHEAP
P/S?
Peers
100
S&P
3
86.53HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-3.4CHEAP
EV/Sales?
Peers
100
S&P
3
122.96HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
97
348.8%STRONG
ROA?
S&P
3
-35.3%WEAK
Cash Flow & Enterprise
FCF?$-51483000
Enterprise Value?$219.4M
Fundamentals ratios updated end of day